Neogen (NEOG) Projected to Post Earnings on Thursday

Neogen (NASDAQ:NEOG) is expected to issue its Q2 2026 results before the market opens on Thursday, January 8th. Analysts expect the company to announce earnings of $0.08 per share and revenue of $208.50 million for the quarter. Parties may visit the the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Thursday, January 8, 2026 at 8:00 AM ET.

Neogen Price Performance

Neogen stock opened at $7.26 on Tuesday. The stock has a 50-day moving average price of $6.47 and a two-hundred day moving average price of $5.80. Neogen has a 12 month low of $3.87 and a 12 month high of $13.40. The company has a market capitalization of $1.58 billion, a PE ratio of -1.51 and a beta of 1.96. The company has a current ratio of 3.58, a quick ratio of 2.26 and a debt-to-equity ratio of 0.37.

Analysts Set New Price Targets

NEOG has been the subject of a number of research reports. Wall Street Zen upgraded shares of Neogen from a “hold” rating to a “buy” rating in a report on Saturday, December 13th. CJS Securities raised shares of Neogen from a “market perform” rating to an “outperform” rating and set a $10.00 price target for the company in a research note on Wednesday, December 10th. Piper Sandler set a $6.50 price objective on shares of Neogen and gave the stock a “neutral” rating in a research note on Thursday, October 16th. Finally, Weiss Ratings restated a “sell (e+)” rating on shares of Neogen in a report on Monday, December 29th. Two analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $8.83.

Institutional Trading of Neogen

A number of large investors have recently bought and sold shares of the business. AQR Capital Management LLC lifted its stake in shares of Neogen by 217.0% in the 1st quarter. AQR Capital Management LLC now owns 52,410 shares of the company’s stock valued at $443,000 after purchasing an additional 35,878 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in Neogen by 4.5% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 129,813 shares of the company’s stock worth $1,125,000 after purchasing an additional 5,638 shares in the last quarter. Jones Financial Companies Lllp lifted its stake in Neogen by 5,687.3% in the first quarter. Jones Financial Companies Lllp now owns 33,393 shares of the company’s stock valued at $290,000 after buying an additional 32,816 shares during the period. Goldman Sachs Group Inc. lifted its stake in Neogen by 14.3% in the first quarter. Goldman Sachs Group Inc. now owns 1,678,493 shares of the company’s stock valued at $14,553,000 after buying an additional 209,990 shares during the period. Finally, United Services Automobile Association bought a new position in shares of Neogen during the 1st quarter worth approximately $112,000. 96.73% of the stock is currently owned by institutional investors and hedge funds.

About Neogen

Neogen Corporation is a global provider of food and animal safety products, offering a broad portfolio of diagnostic and testing solutions. Headquartered in Lansing, Michigan, the company develops and manufactures tests designed to detect foodborne pathogens, allergens and toxins in food, beverage and environmental samples. Since its founding in 1982, Neogen has focused on delivering rapid, accurate and user‐friendly assays to food processors, grain handlers and quality laboratories around the world.

In the food safety arena, Neogen’s product lineup includes immunoassay kits, molecular diagnostics and enrichment media for pathogens such as Salmonella, Listeria and E.